Home › Funds › BOURNE LENT ASSET MANAGEMENT INC › BSX

BOURNE LENT ASSET MANAGEMENT INC position in BSX

BOSTON SCIENTIFIC CORP · Health Care

BOURNE LENT ASSET MANAGEMENT INC reported holding 11,484 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$501K, representing 0.17% of its reported portfolio and ranking #46 among its reported holdings. BOURNE LENT ASSET MANAGEMENT INC has disclosed BSX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)11.48K sh
Reported value held$501.28K
Portfolio Weight0.17%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How BOURNE LENT ASSET MANAGEMENT INC's BSX position evolved

BOURNE LENT ASSET MANAGEMENT INC first disclosed a stake in BSX in Q3 2023 at 17,769 shares (US$938K). The position peaked in Q1 2025 at 15,898 shares, worth US$1.6M. Across 13 filings, BOURNE LENT ASSET MANAGEMENT INC increased the stake 0 time(s), trimmed it 4 time(s) and left it unchanged 8 time(s). The most recent filing (Q3 2026) shows 11,484 shares valued at US$501K — a reduction of -1,093 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 17.77K $938.20K New
Q4 2023 17.77K $1.03M Hold
Q1 2024 17.77K $1.22M Hold
Q2 2024 17.77K $1.37M Hold
Q3 2024 17.77K $1.49M Hold
Q4 2024 15.95K $1.42M Reduce
Q1 2025 15.90K $1.60M Hold
Q2 2025 14.40K $1.55M Reduce
Q3 2025 14.40K $1.41M Hold
Q4 2025 14.40K $1.37M Hold
Q1 2026 12.58K $789.21K Reduce
Q2 2026 12.58K $536.79K Hold
Q3 2026 11.48K $501.28K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 18 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), MFS Investment Management (US$2.29B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has BOURNE LENT ASSET MANAGEMENT INC held BSX?

BOURNE LENT ASSET MANAGEMENT INC has disclosed BSX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is BOURNE LENT ASSET MANAGEMENT INC's current position in BSX?

As of Q3 2026, BOURNE LENT ASSET MANAGEMENT INC holds 11.48K shares of BSX (BOSTON SCIENTIFIC CORP), valued at $501.28K, representing 0.17% of its reported portfolio and ranking #46.

Has BOURNE LENT ASSET MANAGEMENT INC been buying or selling BSX?

In the latest 13F filing (Q3 2026), BOURNE LENT ASSET MANAGEMENT INC reduced its position in BSX. The position peaked in Q1 2025 at 15.90K shares.

Which other funds hold BSX?

Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, MFS Investment Management, D. E. Shaw & Co, among 18 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.